Xiang Liao
Director/Board Member at CLOVER BIOPHARMACEUTICALS, LTD.
Net worth: 13 266 $ as of 29/04/2024
Profile
Xiang Liao is currently the Chief Executive Officer at Novastream Biotech Co. Ltd.
and an Independent Non-Executive Director at Clover Biopharmaceuticals Ltd.
Previously, he worked as the Director of Corporate Development at Sanofi Pasteur from 1992 to 2007.
Mr. Liao holds an MBA from The Trustees of Columbia University in The City of New York, a graduate degree from the University of Scranton, and an undergraduate degree from West China University of Medical Sciences.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2024 | 300,750 ( 0.02% ) | 13 266 $ | 29/04/2024 |
Xiang Liao active positions
| Companies | Position | Start |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Director/Board Member | 18/04/2021 |
| Novastream Biotech Co. Ltd. | Chief Executive Officer | 29/02/2012 |
Former positions of Xiang Liao
| Companies | Position | End |
|---|---|---|
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Corporate Officer/Principal | 30/11/2007 |
Training of Xiang Liao
| West China University of Medical Sciences | Undergraduate Degree |
| University of Scranton | Graduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Private companies | 2 |
|---|---|
| Novastream Biotech Co. Ltd. | |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
- Stock Market
- Insiders
- Xiang Liao
